Four-month-old with severe <i>PIK3CA</i>-related overgrowth spectrum disorder successfully treated with alpelisb
dc.contributor.author | Cossio, Maria-Laura | |
dc.contributor.author | Rodriguez, Josefina | |
dc.contributor.author | Flores, Juan Carlos | |
dc.contributor.author | De Barbieri, Florencia | |
dc.contributor.author | Flores, Alvaro | |
dc.contributor.author | Marin, Jose | |
dc.contributor.author | Florin, Carla | |
dc.contributor.author | Cuevas, Francisco | |
dc.contributor.author | Gutierrez, Monserrat | |
dc.date.accessioned | 2025-01-20T17:08:20Z | |
dc.date.available | 2025-01-20T17:08:20Z | |
dc.date.issued | 2024 | |
dc.description.abstract | PIK3CA-related overgrowth spectrum (PROS) encompasses different clinical entities caused by somatic activating mutations in PIK3CA. Among PROS, CLOVES syndrome represents a severe phenotype with poor survival rate. We present the case of a 4-month-old girl with CLOVES syndrome successfully treated with alpelisib, a PIKC3A inhibitor. | |
dc.fuente.origen | WOS | |
dc.identifier.doi | 10.1111/pde.15582 | |
dc.identifier.eissn | 1525-1470 | |
dc.identifier.issn | 0736-8046 | |
dc.identifier.uri | https://doi.org/10.1111/pde.15582 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/90940 | |
dc.identifier.wosid | WOS:001180107300001 | |
dc.issue.numero | 4 | |
dc.language.iso | en | |
dc.pagina.final | 717 | |
dc.pagina.inicio | 714 | |
dc.revista | Pediatric dermatology | |
dc.rights | acceso restringido | |
dc.subject | pharmacotherapy | |
dc.subject | vascular anomalies | |
dc.subject | vascular malformations | |
dc.subject.ods | 03 Good Health and Well-being | |
dc.subject.odspa | 03 Salud y bienestar | |
dc.title | Four-month-old with severe <i>PIK3CA</i>-related overgrowth spectrum disorder successfully treated with alpelisb | |
dc.type | artículo | |
dc.volumen | 41 | |
sipa.index | WOS | |
sipa.trazabilidad | WOS;2025-01-12 |